# Natasha Leighl, M.D. – FDA Inspection, Nov 22, 2024

Source: https://www.keypedia.com/records/fda_inspections/natasha-leighl-md/c73a951a-c06b-45e2-a16a-36b1d4d906c1
Source feed: FDA_Inspections

> FDA inspection 1255845 of Natasha Leighl, M.D., November 22, 2024. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 50. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1255845
- Company Name: Natasha Leighl, M.D.
- Inspection Date: 2024-11-22
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 1

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/kristin-m-abaonza/cf909da8-837d-4dfe-9ccc-288b24d7bba3)

Company: https://www.keypedia.com/companies/natasha-leighl-md/d407cb57-100b-4a87-bee1-f423da146083

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8